Biotech | The Wall Street Analyzer

Prodex, Inc (NASDAQ: PDEX)

October 26, 2023 The Wall Street Analyzer Comments Off

Interview update with Rick Van Kirk, CEO […]

Biotech

Prodex, Inc (NASDAQ: PDEX)

June 20, 2023 The Wall Street Analyzer Comments Off

Interview with Rick Van Kirk, CEO […]

Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe

October 1, 2019 The Wall Street Analyzer Comments Off

Generex Biotechnology Corporation is an integrated healthcare holding company with end‐to‐end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. […]

Biotech

Eastgate Biotech Corp (OTC: ETBI) Management Interview

September 11, 2019 The Wall Street Analyzer Comments Off

Interview with COO Bill Abajian […]

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

August 12, 2019 The Wall Street Analyzer Comments Off

Interview with Dwight Egan, CEO […]

Generex Biotechnology Announces Interview with CEO Joe Moscato

August 8, 2019 The Wall Street Analyzer Comments Off

MIRAMAR, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (OTCQB:GNBT) today announced that Joe Moscato, the company’s President & Chief Executive Officer conducted an interview with the Wall Street Analyzer, which is available […]

EastGate Biotech Files Application to Initiate Phase III Clinical Trial for Insugin

June 26, 2019 The Wall Street Analyzer Comments Off

Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan […]

EastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 diabetes patients

May 15, 2019 The Wall Street Analyzer Comments Off

Multi-Center Phase III trial planned for 2019
[…]

Biotech

Anna Gluskin, CEO of Eastgate BioTech (OTC: ETBI) discusses positive results and how they are ready to take the Insulin market by storm.

May 2, 2019 The Wall Street Analyzer Comments Off

“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]

EastGate Biotech (OTC: PINK: ETBI) Announces Positive Phase II Clinical Results of its Innovative Liquid Insulin Mouth Rinse Solution for Type 2 Diabetes

April 24, 2019 The Wall Street Analyzer Comments Off

Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a day […]

Featured Interviews

ClearBlue Technologies International (TSXV: CBLU)(OTC: CBUTF)

December 27, 2023 0

Clear Blue Technologies International, the leader in Smart Power, was founded on a vision of delivering clean, managed, “wireless power” to meet the global need for reliable, low-cost, solar and hybrid power for lighting, telecom, security, Internet of Things devices, and other mission-critical systems. Today, Clear Blue is working with its customers “On the Road to Zero Diesel”. […]

Featured Interviews

Platinex Inc. (CSE: PTX)(OTCQB: PANXF)

December 11, 2023 0

Platinex Inc. creates shareholder value through the opportunistic acquisition and advancement of high-quality projects in prolific Ontario mining camps. Current assets include a 100% ownership interest in the W2 Copper-Nickel-PGE Project near the “Ring of Fire” in northern Ontario and a 75% interest in the South Timmins Mining joint venture with Fancamp Exploration, which is focused on gold exploration along the Ridout-Tyrell Deformation Zone near IAMGOLD’s Côté Gold operation in the southwest Abitibi. […]